BCAT1, IKZF1 and SEPT9: methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas

References

• Andresen K, Boberg KM, Vedeld HM, Honne H, Jebsen P, Hektoen M, Wadsworth CA, Clausen OP, Lundin KE, Paulsen V, et al. 2015. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology 61(5):1651–1659. doi: 10.1002/hep.27707
   PubMed Web of Science ®Google Scholar
• Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. 2020. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159(1):335–349 e315. doi: 10.1053/j.gastro.2020.02.068
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. 2023. National Bowel Cancer Screening Program monitoring report 2023. AIHW, Canberra. CAN 154 112. https://www.aihw.gov.au/reports/cancer-screening/nbcsp-monitoring-2023/summary.
   Google Scholar
• Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al. 2014. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 6(224):224ra24. doi: 10.1126/scitranslmed.3007094
   PubMed Web of Science ®Google Scholar
• Bhatia A, Shatanof RA, Bordoni B. 2023. Embryology, Gastrointestinal. StatPearls Publishing, Treasure Island, Florida.
   Google Scholar
• Chan MM, Winter JM, Pedersen SK, Roy AC, Watson DI, Hussey D, Young GP, Symonds EL. 2022. Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a potential diagnostic and prognostic biomarker in esophagogastic cancers. JCO. 40(4_suppl):348–348. doi: 10.1200/JCO.2022.40.4_suppl.348
   Web of Science ®Google Scholar
• Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, et al. 2014. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 63(2):317–325., doi: 10.1136/gutjnl-2012-304149
   PubMed Web of Science ®Google Scholar
• Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al. 2016. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44(8):e71–e71. doi: 10.1093/nar/gkv1507
   PubMed Web of Science ®Google Scholar
• Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. 2010. Comparison of beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf. 11(1):587. doi: 10.1186/1471-2105-11-587
   PubMedGoogle Scholar
• Engler J. 2022. Tidyheatmaps: heatmaps from Tidy Date. R package version 0.1.0. https://github.com/jbengler/tidyheatmaps.
   Google Scholar
• Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al. 2013. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 49(2):359–367. doi: 10.1016/j.molcel.2012.10.016
   PubMed Web of Science ®Google Scholar
• Harrold E, Latham A, Pemmaraju N, Lieu CH. 2023. Early-onset GI cancers: rising trends, genetic risks, novel strategies, and special considerations. Am Soc Clin Oncol Educ Book 43:e398068. doi: 10.1200/EDBK_398068
   PubMedGoogle Scholar
• Hu J, Hu B, Gui YC, Tan ZB, Xu JW. 2019. Diagnostic value and clinical significance of methylated sept9 for colorectal cancer: a meta-analysis. Med Sci Monit. 25:5813–5822. doi: 10.12659/MSM.915472
   PubMed Web of Science ®Google Scholar
• Johnston AD, Ross JP, Ma C, Fung KYC, Locke WJ. 2023. Epigenetic liquid biopsies for minimal residual disease, what’s around the corner? Front Oncol. 13:1103797. doi: 10.3389/fonc.2023.1103797
   PubMed Web of Science ®Google Scholar
• Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ. 2004. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32(Database issue):D493–496. doi: 10.1093/nar/gkh103
   PubMed Web of Science ®Google Scholar
• Kuhn M, Vaughan D, Hvitfelt E, Posit Software P. 2023. yardstick: tidy characterizations of model performance. R package version 1.2.0. https://cran.r-project.org/web/packages/yardstick/index.html.
   Google Scholar
• Laird PW. 2003. The power and the promise of DNA methylation markers. Nat Rev Cancer 3(4):253–266. doi: 10.1038/nrc1045
   PubMed Web of Science ®Google Scholar
• Lamb YN, Dhillon S. 2017. Epi proColon((R)) 2.0 CE: A blood-based screening test for colorectal cancer. Mol Diagn Ther. 21(2):225–232. doi: 10.1007/s40291-017-0259-y
   PubMed Web of Science ®Google Scholar
• Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R, Morgan MT, Carey VJ. 2013. Software for computing and annotating genomic ranges. PLoS Comput Biol. 9(8):e1003118. doi: 10.1371/journal.pcbi.1003118
   PubMed Web of Science ®Google Scholar
• Levenson VV. 2010. DNA methylation as a universal biomarker. Expert Rev Mol Diagn. 10(4):481–488. doi: 10.1586/erm.10.17
   PubMed Web of Science ®Google Scholar
• Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, & Consortium, C. 2020. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 31(6):745–759. doi: 10.1016/j.annonc.2020.02.011
   PubMed Web of Science ®Google Scholar
• Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, Ross JP. 2019. DNA Methylation Cancer Biomarkers: Translation to the Clinic. Front Genet. 10:1150. doi: 10.3389/fgene.2019.01150
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, et al. 2008. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 54(2):414–423. doi: 10.1373/clinchem.2007.095992
   PubMed Web of Science ®Google Scholar
• Maestranzi S, Przemioslo R, Mitchell H, Sherwood RA. 1998. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA. Ann Clin Biochem. 35 (Pt 1)(1):99–103. doi: 10.1177/000456329803500113
   PubMedGoogle Scholar
• Massarweh NN, El-Serag HB. 2017. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control 24(3):1073274817729245. doi: 10.1177/1073274817729245
   Web of Science ®Google Scholar
• Mitchell SM, Ho T, Brown GS, Baker RT, Thomas ML, McEvoy A, Xu ZZ, Ross JP, Lockett TJ, Young GP, et al. 2016. Evaluation of methylation biomarkers for detection of circulating tumor DNA and application to colorectal cancer. Genes (Basel) 7(12):125. doi: 10.3390/genes7120125
   PubMed Web of Science ®Google Scholar
• Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, et al. 2014. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 14(1):54. doi: 10.1186/1471-2407-14-54
   PubMedGoogle Scholar
• Moss J, Magenheim J, Neiman D, Zemmour H, Loyfer N, Korach A, Samet Y, Maoz M, Druid H, Arner P, et al. 2018. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun. 9(1):5068. doi: 10.1038/s41467-018-07466-6
   Google Scholar
• Navarro M, Nicolas A, Ferrandez A, Lanas A. 2017. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol. 23(20):3632–3642. doi: 10.3748/wjg.v23.i20.3632
   PubMed Web of Science ®Google Scholar
• NCI Genomic Data Commons. 2022. Bioinformatics pipeline: methylation analysis. In: GDC data user’s guide, vol. 35.0, pp. 56–57. https://docs.gdc.cancer.gov/Data/Bioinformatics_Pipelines/Expression_mRNA_Pipeline/.
   Google Scholar
• Paulovich AG, Whiteaker JR, Hoofnagle AN, Wang P. 2008. The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteomics Clin Appl. 2(10-11):1386–1402. doi: 10.1002/prca.200780174
   PubMed Web of Science ®Google Scholar
• Pedersen SK, Baker RT, McEvoy A, Murray DH, Thomas M, Molloy PL, Mitchell S, Lockett T, Young GP, LaPointe LC. 2015. A two-gene blood test for methylated DNA sensitive for colorectal cancer. PLoS One. 10(4):e0125041. doi: 10.1371/journal.pone.0125041
   PubMed Web of Science ®Google Scholar
• Pedersen SK, Symonds EL, Roy AC, Cornthwaite KJ, LaPointe LC, Young GP. 2023. Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence. Cancer Med. 12(2):1319–1329. doi: 10.1002/cam4.5008
   PubMed Web of Science ®Google Scholar
• Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, V Lord R, Clark SJ, Molloy PL. 2015. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 8(1):6. doi: 10.1186/1756-8935-8-6
   PubMedGoogle Scholar
• Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, Koenig T, Quigley NB, Weiss G. 2014. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 60(9):1183–1191. doi: 10.1373/clinchem.2013.221044
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7):e47–e47. doi: 10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdottir H, Turner D, Mesirov JP. 2023. igv.js: an embeddable JavaScript implementation of the Integrative Genomics Viewer (IGV). Bioinformatics 39(1):btac830. doi: 10.1093/bioinformatics/btac830
   PubMed Web of Science ®Google Scholar
• Sanz-Garcia E, Zhao E, Bratman SV, Siu LL. 2022. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: current research, opportunities, and challenges. Sci Adv. 8(4):eabi8618. doi: 10.1126/sciadv.abi8618
   PubMed Web of Science ®Google Scholar
• Shirley M. 2020. Epi proColon((R)) for colorectal cancer screening: a profile of its use in the USA. Mol Diagn Ther. 24(4):497–503. doi: 10.1007/s40291-020-00473-8
   PubMed Web of Science ®Google Scholar
• Shvetsov YB, Song MA, Cai Q, Tiirikainen M, Xiang YB, Shu XO, Yu H. 2015. Intraindividual variation and short-term temporal trend in DNA methylation of human blood. Cancer Epidemiol Biomarkers Prev. 24(3):490–497. doi: 10.1158/1055-9965.EPI-14-0853
   PubMed Web of Science ®Google Scholar
• Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J. 2021. Reproducible summary tables with the gtsummary package. The R J. 13(1):570–580. doi: 10.32614/RJ-2021-053
   Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Swanton C, Neal RD, Johnson PWM, Dur CC, Hamilton SA, Zhang N, Kumar H, Sasieni P. 2022. NHS-Galleri trial design: equitable study recruitment tactics for targeted population-level screening with a multi-cancer early detection (MCED) test. JCO. 40(16_suppl):TPS6606–TPS6606. doi: 10.1200/JCO.2022.40.16_suppl.TPS6606
   Web of Science ®Google Scholar
• Symonds EL, Cock C, Meng R, Cole SR, Fraser RJL, Young GP. 2018B. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test. Eur J Cancer Prev. 27(5):425–432. doi: 10.1097/CEJ.0000000000000352
   PubMed Web of Science ®Google Scholar
• Symonds EL, Pedersen SK, Baker RT, Murray DH, Gaur S, Cole SR, Gopalsamy G, Mangira D, LaPointe LC, Young GP. 2016. A blood test for methylated BCAT1 and IKZF1 vs. a fecal immunochemical test for detection of colorectal neoplasia. Clin Transl Gastroenterol. 7(1):e137. doi: 10.1038/ctg.2015.67
   PubMed Web of Science ®Google Scholar
• Symonds EL, Yao B, Pedersen SK, Murray D, Young GP. 2018A. Specificity of methylated BCAT1 and IKZF1 for colorectal cancer. JCO 36(4_suppl):580–580. doi: 10.1200/JCO.2018.36.4_suppl.580
   Google Scholar
• Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, The Cancer Genome Atlas Research Network. 2013. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 45(10):1113–1120. doi: 10.1038/ng.2764
   PubMed Web of Science ®Google Scholar
• Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, Grolemund G, Hayes A, Henry L, Hester J, et al. 2019. Welcome to the Tidyverse. JOSS. 4(43):1686. doi: 10.21105/joss.01686
   Google Scholar
• Winter JM, Sheehan-Hennessy L, Pedersen SK, Young GP, Symonds EL. 2022A. Detection of circulating DNA methylated BCAT1 and IKZF1 in pancreatic adenocarcinoma. JCO. 40(4_suppl):597–597. doi: 10.1200/JCO.2022.40.4_suppl.597
   Web of Science ®Google Scholar
• Winter JM, Sheehan-Hennessy L, Yao B, Pedersen SK, Wassie MM, Eaton M, Chong M, Young GP, Symonds EL. 2022B. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients. Cancer Biomark. 34(3):493–503. doi: 10.3233/CBM-210399
   PubMed Web of Science ®Google Scholar
• Wise J. 2022. A blood test for multiple cancers: game changer or overhyped? BMJ 378:o2279. doi: 10.1136/bmj.o2279
   PubMedGoogle Scholar
• World Cancer Research Fund International. 2020. Worldwide cancer data. https://www.wcrf.org/cancer-trends/worldwide-cancer-data/.
   Google Scholar
• Zaimi I, Pei D, Koestler DC, Marsit CJ, De Vivo I, Tworoger SS, Shields AE, Kelsey KT, Michaud DS. 2018. Variation in DNA methylation of human blood over a 1-year period using the Illumina MethylationEPIC array. Epigenetics 13(10-11):1056–1071. doi: 10.1080/15592294.2018.1530008
   PubMed Web of Science ®Google Scholar
• Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, Vishwanatha JK, Santella RM, Morabia A. 2011. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 6(5):623–629. doi: 10.4161/epi.6.5.15335
   PubMed Web of Science ®Google Scholar